Educational interventions delivered to prescribing advisers to influence primary care prescribing: a very low-cost pragmatic randomised trial using routine data from OpenPrescribing.net
Curtis HJ. et al, (2025), BMC health services research, 25
Antibiotics for common infections in primary care before, during and after the COVID-19 pandemic: cohort study of extent of prescribing based on risks of infection-related hospital admissions
Fahmi A. et al, (2025), Journal of the Royal Society of Medicine
Using Laboratory Test Results for Surveillance During a New Outbreak of Acute Hepatitis in 3-Week- to 5-Year-Old Children in the United Kingdom, the Netherlands, Ireland, and Curaçao: Observational Cohort Study.
Swets MC. et al, (2024), JMIR Public Health Surveill, 10
Healthcare utilisation in people with long COVID: an OpenSAFELY cohort study
Lin LY. et al, (2024), BMC Medicine, 22
Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform
Costello RE. et al, (2024), Communications Medicine, 4
The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19
Bechman K. et al, (2024), Journal of Infection, 89
Therapeutics Dataset from COVID-19 Medicine Delivery Units in England: an OpenSAFELY Data Report
Nab L. et al, (2024), Wellcome Open Research, 9, 425 - 425
Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people
Taylor K. et al, (2024), The Lancet Diabetes and Endocrinology, 12, 558 - 568
Changes in sick notes associated with COVID-19 from 2020 to 2022: A cohort study in 24 million primary care patients in OpenSAFELY-TPP
Schaffer AL. et al, (2024), BMJ Open, 14
Interpreting pathology test result values with comparators (< , >) in Electronic Health Records research: an OpenSAFELY short data report
Curtis HJ. et al, (2024), Wellcome Open Research, 8, 541 - 541
Changes in opioid prescribing during the COVID-19 pandemic in England: an interrupted time-series analysis in the OpenSAFELY-TTP cohort
Schaffer AL. et al, (2024), The Lancet Public Health, 9, e432 - e442
Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPP.
Horne EMF. et al, (2024), Epidemiology (Cambridge, Mass.), 35, 568 - 578